This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...